InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Browse the full record of transactions filed by Geffner Michael, Chief Medical Officer. Director active across 1 companies, notably Immunovant, Inc.. In total, 6 filings have been recorded. Total volume traded: €155k. The latest transaction was filed on 22 October 2025 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
US$42,5402,595 shares@ US$16.39320.0008% mcap55.0% of flow
Common Stock
SEC:0001764013-25-000144·
€42,5402,595 shares@ €16.39320.0008% mcap27.5% of flow
Common Stock
SEC:0001764013-25-000144:0·
US$17,8251,272 shares@ US$14.01310.0003% mcap23.0% of flow
Common Stock
SEC:0001764013-25-000140·
€17,8251,272 shares@ €14.01310.0003% mcap11.5% of flow
Common Stock
SEC:0001764013-25-000140:0·
US$17,0471,160 shares@ US$14.69590.0003% mcap22.0% of flow
Common Stock
SEC:0001764013-25-000109·
€17,0471,160 shares@ €14.69590.0003% mcap11.0% of flow
Common Stock
SEC:0001764013-25-000109:0·
6 of 6 declarations
About Geffner Michael
Michael Geffner serves as Chief Medical Officer at Immunovant, Inc. In this role, he is responsible for leading the company's medical and clinical initiatives, ensuring that products and services meet health and safety standards. His medical expertise is essential for the development of innovative treatments.
